PetVivo Holdings, Inc. (PETV) は上場企業です ヘルスケア セクターの Medical - Devices 業界で事業展開. 本社所在地は Minneapolis, MN, アメリカ. 現CEOは John Lai.
PETV を有する IPO日 2014-09-08, 20 名の正社員, に上場 Other OTC, 時価総額 $21.66M.
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.
